Correlation Between Navidea Biopharmaceutica and Xilio Development
Can any of the company-specific risk be diversified away by investing in both Navidea Biopharmaceutica and Xilio Development at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Navidea Biopharmaceutica and Xilio Development into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Navidea Biopharmaceuticals and Xilio Development, you can compare the effects of market volatilities on Navidea Biopharmaceutica and Xilio Development and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Navidea Biopharmaceutica with a short position of Xilio Development. Check out your portfolio center. Please also check ongoing floating volatility patterns of Navidea Biopharmaceutica and Xilio Development.
Diversification Opportunities for Navidea Biopharmaceutica and Xilio Development
-0.21 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Navidea and Xilio is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Navidea Biopharmaceuticals and Xilio Development in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xilio Development and Navidea Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Navidea Biopharmaceuticals are associated (or correlated) with Xilio Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xilio Development has no effect on the direction of Navidea Biopharmaceutica i.e., Navidea Biopharmaceutica and Xilio Development go up and down completely randomly.
Pair Corralation between Navidea Biopharmaceutica and Xilio Development
Given the investment horizon of 90 days Navidea Biopharmaceuticals is expected to generate 0.95 times more return on investment than Xilio Development. However, Navidea Biopharmaceuticals is 1.05 times less risky than Xilio Development. It trades about 0.03 of its potential returns per unit of risk. Xilio Development is currently generating about -0.01 per unit of risk. If you would invest 10.00 in Navidea Biopharmaceuticals on August 28, 2024 and sell it today you would lose (0.04) from holding Navidea Biopharmaceuticals or give up 0.4% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 4.24% |
| Values | Daily Returns |
Navidea Biopharmaceuticals vs. Xilio Development
Performance |
| Timeline |
| Navidea Biopharmaceutica |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Xilio Development |
Navidea Biopharmaceutica and Xilio Development Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Navidea Biopharmaceutica and Xilio Development
The main advantage of trading using opposite Navidea Biopharmaceutica and Xilio Development positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Navidea Biopharmaceutica position performs unexpectedly, Xilio Development can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xilio Development will offset losses from the drop in Xilio Development's long position.| Navidea Biopharmaceutica vs. NovaBay Pharmaceuticals | Navidea Biopharmaceutica vs. Cyclacel Pharmaceuticals | Navidea Biopharmaceutica vs. Tenax Therapeutics |
| Xilio Development vs. Connect Biopharma Holdings | Xilio Development vs. Tyra Biosciences | Xilio Development vs. RAPT Therapeutics | Xilio Development vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |